Arthur Cox was very pleased to advise Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company, on its recommended acquisition by Xeris Pharmaceuticals, Inc.

The Arthur Cox team was led by Maura McLaughlin (Corporate and M&A) and included Conor O’Keeffe, Andrea Bowdren and Patrick Munnelly (Corporate and M&A) and Fintan Clancy and Nicola Cavey (Tax).